Ibnsina Pharma (EGX:ISPH)

Egypt flag Egypt · Delayed Price · Currency is EGP
11.21
-0.58 (-4.92%)
At close: Mar 1, 2026
68.83%
Market Cap 11.67B
Revenue (ttm) 76.60B
Net Income (ttm) 951.98M
Shares Out 1.01B
EPS (ttm) 0.76
PE Ratio 15.24
Forward PE 8.51
Dividend 0.16 (1.43%)
Ex-Dividend Date Oct 13, 2025
Volume 8,446,264
Average Volume 8,696,504
Open 11.79
Previous Close 11.79
Day's Range 10.90 - 11.59
52-Week Range 6.60 - 13.72
Beta 0.59
RSI 41.58
Earnings Date Feb 25, 2026

About Ibnsina Pharma

Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, hospitals, and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services, as well as value added services. The company was founded in 2001 and is headquartered in El Obour City, Egypt. [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 2001
Employees 5,500
Stock Exchange Egyptian Stock Exchange
Ticker Symbol ISPH
Full Company Profile

Financial Performance

In 2025, Ibnsina Pharma's revenue was 76.60 billion, an increase of 37.17% compared to the previous year's 55.84 billion. Earnings were 951.98 million, an increase of 91.24%.

Financial Statements

News

There is no news available yet.